-transparent.png){kind=logo}
BACKGROUND Lymphoid cells may express somatostatin receptors (SS-Rs) on their cell surface. Therefore radiolabeled somatostatin analogues may be used to visualize SS-R-positive lymphoid neoplasms in vivo. Exact staging is the basis for treatment decisions in cutaneous malignant lymphoma. We considered the possibility that SS-R scintigraphy might offer a clinically useful method of diagnostic imaging in patients with cutaneous malignant lymphoma. OBJECTIVE We evaluated SS-R scintigraphy in comparison with conventional staging methods in the staging of cutaneous malignant lymphoma. METHODS We conducted a prospective study in 14 consecutive patients with histologically proven cutaneous malignant lymphoma. SS-R scintigraphy was compared with physical, radiologic, and bone marrow examinations. Lymph node excisions were performed in patients with palpable lymph nodes. RESULTS SS-R scintigraphy was positive in the lymph nodes in all four patients with malignant lymph node infiltration and negative in the three patients with dermatopathic lymphadenopathy. In two patients, previously unsuspected lymphoma localizations were visualized by SS-R scintigraphy. In only three patients all skin lesions were visualized by SS-R scintigraphy; these three patients had not been treated with topical corticosteroids. SS-R scintigraphy failed to detect an adrenal mass in one patient and bone marrow infiltration in two patients. CONCLUSIONS SS-R scintigraphy may help distinguish dermatopathic lymphadenopathy from malignant lymph node infiltration in patients with cutaneous malignant lymphoma.
P J van den Anker-Lugtenburg, and
F Heule, and
P M Vanhagen, and
T van Joost, and
H Y Oei, and
B Löwenberg, and
E P Krenning
January 1993,
British journal of haematology,
P J van den Anker-Lugtenburg, and
F Heule, and
P M Vanhagen, and
T van Joost, and
H Y Oei, and
B Löwenberg, and
E P Krenning
January 2010,
Journal of the European Academy of Dermatology and Venereology : JEADV,
P J van den Anker-Lugtenburg, and
F Heule, and
P M Vanhagen, and
T van Joost, and
H Y Oei, and
B Löwenberg, and
E P Krenning
June 1997,
Leukemia & lymphoma,
P J van den Anker-Lugtenburg, and
F Heule, and
P M Vanhagen, and
T van Joost, and
H Y Oei, and
B Löwenberg, and
E P Krenning
January 1995,
Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
P J van den Anker-Lugtenburg, and
F Heule, and
P M Vanhagen, and
T van Joost, and
H Y Oei, and
B Löwenberg, and
E P Krenning
January 1997,
The Yale journal of biology and medicine,
P J van den Anker-Lugtenburg, and
F Heule, and
P M Vanhagen, and
T van Joost, and
H Y Oei, and
B Löwenberg, and
E P Krenning
August 1996,
Metabolism: clinical and experimental,
P J van den Anker-Lugtenburg, and
F Heule, and
P M Vanhagen, and
T van Joost, and
H Y Oei, and
B Löwenberg, and
E P Krenning
December 2005,
Ugeskrift for laeger,
P J van den Anker-Lugtenburg, and
F Heule, and
P M Vanhagen, and
T van Joost, and
H Y Oei, and
B Löwenberg, and
E P Krenning
January 1989,
La Tunisie medicale,
P J van den Anker-Lugtenburg, and
F Heule, and
P M Vanhagen, and
T van Joost, and
H Y Oei, and
B Löwenberg, and
E P Krenning
March 1998,
Immunology today,
P J van den Anker-Lugtenburg, and
F Heule, and
P M Vanhagen, and
T van Joost, and
H Y Oei, and
B Löwenberg, and
E P Krenning
October 1980,
Zeitschrift fur Hautkrankheiten,
